PHASE I - SMALL MOLECULE LEADING THERAPIES PIPELINE
Tillat Manufactures Leading Medications in the World, in a Halal-Compliant Manner. Expected in Market by 2H24.
PHASE I - BIOTHERAPEUTIC LEADING THERAPIES PIPELINE
Tillat Manufactures Leading Medications in the World, in a Halal-Compliant Manner. Expected in Market by 1H25
